Pricing Log in Create free account
Friday 6 November 2026 Export VTRS’s income statement to Excel — free account

Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.

Revenue
−0.28%
EPS
−154.6%
Free cash flow
+38.8%
Total debt
−89.4%

Quarter to September 2026, against a year earlier

18.89 0.33 −1.72%
Market cap
$21.8B
P/E
0.0×
Fwd P/E
82.6×
Dividend yield
2.54%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Valuation Filings

Viatris Inc. (VTRS) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Viatris Inc. (VTRS) trades at a EV/EBITDA of 12.3×. Over the past ten years it has ranged from 6.3× (March 2023) to 22.0× (April 2015); the current reading is higher than 77% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 12.2× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 9.0× (3.55%)
FY2024 9.3× 23.86%
FY2023 7.5× 10.04%
FY2022 6.9× (20.90%)
FY2021 8.7× (55.17%)
FY2020 19.3× 124.15%
FY2019 8.6× (5.73%)
FY2018 9.1× (23.39%)
FY2017 11.9× (26.25%)
FY2016 16.2× 27.39%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 11.8× 3.96%
Jun 2026 11.4× 19.32%
Mar 2026 9.5× 5.99%
Dec 2025 9.0× 2.91%
43 more quarters

Against its own ten years

Low 6.3× High 22.0×
Ten-year median 9.5×
Current reading's percentile 77

EV/EBITDA against peers

Company EV/EBITDA
ZTS Zoetis Inc. compare 10.7×
HLN Haleon PLC Sponsored ADR compare 12.2×
VTRS Viatris Inc. 12.3×
UTHR United Therapeutics Corporation compare 14.7×
NBIX Neurocrine Biosciences, Inc. compare 16.5×
ELAN Elanco Animal Health Incorporated compare 19.7×
RDY Dr. Reddy's Laboratories Ltd compare 22.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 26.2×
ALKS Alkermes plc compare 37.9×
Drug Manufacturers Specialty & Generic industry median 12.2×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on VTRS